This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Ewha University-Industry Collaboration Foundation, Sk Chemicals Co., Ltd.. Active years: 2008-2013.
Company Filing History:
2 out of 204 
2 out of 201 
Years Active: 2008-2013
Title: Joon Hun Choi: Innovator in Pharmaceutical Compounds
Introduction
Joon Hun Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific signaling pathways in mammals. With a total of 2 patents, his work is paving the way for advancements in treating various fibrotic conditions.
Latest Patents
Choi's latest patents include innovative compounds such as 2-pyridyl substituted imidazoles, which serve as ALK5 and/or ALK4 inhibitors. These compounds are particularly useful in treating renal, liver, or pulmonary fibrosis. Another patent focuses on the same class of compounds, which are designed to inhibit the TGF-β and/or activin signaling pathway in mammals. These inventions highlight Choi's commitment to addressing critical health issues through scientific innovation.
Career Highlights
Throughout his career, Joon Hun Choi has worked with reputable organizations, including SK Chemicals Co., Ltd. and Ewha University-Industry Collaboration Foundation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Choi has collaborated with notable colleagues such as Dae-Kee Kim and Yung-Jue Bang. These partnerships have further enhanced his research capabilities and have led to the successful development of his patented compounds.
Conclusion
Joon Hun Choi's contributions to pharmaceutical innovations demonstrate his dedication to improving health outcomes through targeted therapies. His patents reflect a promising future in the treatment of fibrotic diseases.